Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion
- PMID: 12483443
- DOI: 10.1007/s00234-002-0872-1
Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion
Abstract
Tumefactive demyelinating lesions can present with features similar, clinically and radiologically, to those of brain tumours. Proton MR spectroscopy has been increasingly used to characterize intracranial pathology. As the underlying pathophysiology of neoplasms is different from that of demyelinating disease, one may expect the metabolic composition of neoplasms to be significantly different from that of demyelinating lesions. We report a 49-year-old woman in whom the neurologic and radiologic findings were highly suggestive of a high-grade brain tumor, and the spectroscopic features were sufficiently similar to that of a tumor to convince the neurosurgeon to operate. This case emphasizes the need for caution when confronted with a patient who presents with a differential diagnosis of demyelinating lesion versus neoplasm.
Similar articles
-
In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.Ann Neurol. 1998 Aug;44(2):273-8. doi: 10.1002/ana.410440222. Ann Neurol. 1998. PMID: 9708554
-
Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.Mult Scler. 2009 Feb;15(2):193-203. doi: 10.1177/1352458508097922. Mult Scler. 2009. PMID: 19181773
-
Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation.J Neuroimaging. 2004 Jul;14(3):285-9. doi: 10.1177/1051228404264957. J Neuroimaging. 2004. PMID: 15228773
-
Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders.Magn Reson Imaging Clin N Am. 1998 Feb;6(1):1-20. Magn Reson Imaging Clin N Am. 1998. PMID: 9449737 Review.
-
MR in the diagnosis and monitoring of multiple sclerosis: an overview.Eur J Radiol. 2008 Sep;67(3):409-14. doi: 10.1016/j.ejrad.2008.02.044. Epub 2008 Apr 22. Eur J Radiol. 2008. PMID: 18434066 Review.
Cited by
-
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.J Med Case Rep. 2012 Apr 6;6:104. doi: 10.1186/1752-1947-6-104. J Med Case Rep. 2012. PMID: 22483341 Free PMC article.
-
Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.AJNR Am J Neuroradiol. 2014 Feb;35(2):270-7. doi: 10.3174/ajnr.A3677. Epub 2013 Aug 8. AJNR Am J Neuroradiol. 2014. PMID: 23928144 Free PMC article.
-
Recent advances in magnetic resonance neurospectroscopy.Neurotherapeutics. 2007 Jul;4(3):330-45. doi: 10.1016/j.nurt.2007.04.009. Neurotherapeutics. 2007. PMID: 17599700 Free PMC article. Review.
-
Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report.Electron Physician. 2018 Aug 25;10(8):7180-7184. doi: 10.19082/7180. eCollection 2018 Aug. Electron Physician. 2018. PMID: 30214700 Free PMC article.
-
A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.Medicine (Baltimore). 2016 Sep;95(36):e4585. doi: 10.1097/MD.0000000000004585. Medicine (Baltimore). 2016. PMID: 27603348 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials